Bottom Line: Rentokil's options
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.SECURIGUARD'S initial defence document said Rentokil's pounds 59.2m hostile bid 'fails to recognise Securiguard's potential'. The sequel, released yesterday, observed: 'Rentokil obviously recognises Securiguard's potential but it is not offering a realistic price.'
Most have been suspecting that Rentokil would have to offer 320p to win compared with 309p yesterday.
That, however, was before Securiguard released its interim results. The half-time dividend was lifted by 29 per cent to 4.5p and the company forecasts a 22 per cent increase in the final.
This is off the back of half- year pre-tax profits which, boosted by a surprise profits increase of 135 per cent in the communications division, rose by a hefty 36 per cent to pounds 3.5m when analysts were looking for just pounds 2.8m, up from pounds 2.6m last time.
So the stakes have risen. New forecasts by analysts, if not the company, put Securiguard on a prospective p/e of 14 based on profits of pounds 7m and a 320p exit share price.
Rentokil could therefore bid up to 350p and still win a company with potential for profits growth and Rentokil cost-cutting at just 15 times its earnings. There is nothing to lose from hanging on.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments